X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5481) 5481
Publication (406) 406
Book Review (56) 56
Book / eBook (48) 48
Book Chapter (21) 21
Dissertation (5) 5
Magazine Article (5) 5
Conference Proceeding (3) 3
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4847) 4847
female (2715) 2715
oncology (2564) 2564
male (2563) 2563
index medicus (2273) 2273
adult (2063) 2063
middle aged (1879) 1879
soft tissue neoplasms - drug therapy (1670) 1670
aged (1529) 1529
sarcoma - drug therapy (1356) 1356
sarcoma (1308) 1308
chemotherapy (1281) 1281
cancer (1223) 1223
adolescent (1089) 1089
antineoplastic combined chemotherapy protocols - therapeutic use (946) 946
surgery (941) 941
treatment outcome (916) 916
tumors (861) 861
soft tissue neoplasms - pathology (853) 853
child (834) 834
soft-tissue sarcomas (822) 822
combined modality therapy (810) 810
soft-tissue sarcoma (780) 780
prognosis (766) 766
animals (703) 703
sarcoma - pathology (674) 674
antineoplastic agents - therapeutic use (670) 670
soft tissue sarcoma (602) 602
retrospective studies (566) 566
soft tissue neoplasms - surgery (543) 543
care and treatment (535) 535
metastasis (520) 520
aged, 80 and over (517) 517
bone neoplasms - drug therapy (501) 501
radiotherapy (471) 471
child, preschool (468) 468
follow-up studies (455) 455
soft tissue neoplasms - therapy (455) 455
medicine & public health (436) 436
sarcoma - surgery (436) 436
doxorubicin - administration & dosage (433) 433
doxorubicin (400) 400
neoplasm staging (397) 397
sarcoma - therapy (396) 396
young adult (391) 391
disease-free survival (389) 389
therapy (385) 385
survival (382) 382
research (381) 381
pathology (376) 376
survival rate (372) 372
chemotherapy, adjuvant (356) 356
radiology, nuclear medicine & medical imaging (351) 351
analysis (350) 350
diagnosis (341) 341
pediatrics (337) 337
soft tissue neoplasms - radiotherapy (324) 324
health aspects (323) 323
infant (323) 323
soft-tissue (317) 317
neoplasm metastasis (316) 316
prognostic-factors (316) 316
sarcoma - mortality (313) 313
soft tissue neoplasms - mortality (303) 303
mice (302) 302
survival analysis (301) 301
sarcoma - radiotherapy (297) 297
immunohistochemistry (285) 285
drug therapy (282) 282
soft tissue neoplasms - diagnosis (282) 282
ifosfamide (281) 281
antineoplastic agents - administration & dosage (279) 279
patients (275) 275
ifosfamide - administration & dosage (272) 272
drug administration schedule (270) 270
hematology (267) 267
children (260) 260
extremities (257) 257
soft tissue neoplasms - secondary (257) 257
expression (254) 254
cell line, tumor (252) 252
phase-ii (252) 252
hematology, oncology and palliative medicine (250) 250
lung neoplasms - secondary (250) 250
pharmacology & pharmacy (250) 250
osteosarcoma (249) 249
neoplasms - drug therapy (247) 247
bone neoplasms - pathology (245) 245
medicine (245) 245
dose-response relationship, drug (244) 244
antineoplastic combined chemotherapy protocols - adverse effects (242) 242
time factors (242) 242
doxorubicin - therapeutic use (240) 240
risk factors (235) 235
radiation-therapy (232) 232
clinical trials as topic (231) 231
magnetic resonance imaging (230) 230
phase-ii trial (229) 229
cancer therapies (223) 223
research article (213) 213
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (40) 40
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Mt Sinai Hospital - Pathology (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5162) 5162
German (132) 132
Japanese (84) 84
French (69) 69
Russian (34) 34
Chinese (19) 19
Italian (15) 15
Spanish (12) 12
Polish (11) 11
Czech (2) 2
Dutch (2) 2
Finnish (2) 2
Hungarian (2) 2
Turkish (2) 2
Afrikaans (1) 1
Arabic (1) 1
Bulgarian (1) 1
Danish (1) 1
Portuguese (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Oncology, ISSN 1470-2045, 11/2017, Volume 18, Issue 11, pp. 1493 - 1501
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2008, Volume 26, Issue 32, pp. 5269 - 5274
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9829, pp. 1879 - 1886
Journal Article
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1397 - 1410
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 949 - 956
Summary Background Diffuse-type tenosynovial giant cell tumour (dt-GCT) of the soft tissue (alternatively known as pigmented villonodular synovitis), an orphan... 
Hematology, Oncology and Palliative Medicine | PIGMENTED VILLONODULAR SYNOVITIS | DIAGNOSIS | THERAPY | EFFICACY | ONCOLOGY | PERIORBITAL EDEMA SECONDARY | MACROPHAGES | RECEPTOR | ANTIBODY | ARTHRITIS | IMATINIB MESYLATE | Receptor, Macrophage Colony-Stimulating Factor - antagonists & inhibitors | Receptor, Macrophage Colony-Stimulating Factor - immunology | Giant Cell Tumors - immunology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Giant Cell Tumors - pathology | Soft Tissue Neoplasms - drug therapy | Male | Antineoplastic Agents - administration & dosage | Giant Cell Tumors - metabolism | Receptor, Macrophage Colony-Stimulating Factor - metabolism | Synovitis, Pigmented Villonodular - drug therapy | Synovitis, Pigmented Villonodular - pathology | Soft Tissue Neoplasms - immunology | Young Adult | Time Factors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Drug Administration Schedule | Soft Tissue Neoplasms - metabolism | Synovitis, Pigmented Villonodular - metabolism | Treatment Outcome | Synovitis, Pigmented Villonodular - immunology | Giant Cell Tumors - drug therapy | Signal Transduction - drug effects | Antibodies, Monoclonal - administration & dosage | Adolescent | Soft Tissue Neoplasms - pathology | Aged | Infusions, Intravenous | Monoclonal antibodies | Macrophage colony stimulating factor | Tumors
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 76, pp. 84 - 92
Abstract Background Preclinical models that mimic pathological and molecular features of solitary fibrous tumour (SFT) represent an important tool to select... 
Hematology, Oncology and Palliative Medicine | Eribulin | Xenograft | Sarcoma | Ifosfamide | Mice model | Solitary fibrous tumour | Metastasis | Trabectedin | Doxorubicin | Dacarbazine | Chemotherapy | Treatment | Anthracycline | MECHANISM | PHASE-2 | IDENTIFICATION | TEMOZOLOMIDE | MESYLATE | ONCOLOGY | RECURRENT | HEMANGIOPERICYTOMA | EXPRESSION | SOFT-TISSUE SARCOMA | Humans | Middle Aged | Soft Tissue Neoplasms - drug therapy | Male | Response Evaluation Criteria in Solid Tumors | Pleural Neoplasms - drug therapy | Retroperitoneal Neoplasms - mortality | Meningeal Neoplasms - drug therapy | Retroperitoneal Neoplasms - drug therapy | Dioxoles - administration & dosage | Adult | Female | Retrospective Studies | Doxorubicin - administration & dosage | Cerebellar Neoplasms - drug therapy | Dacarbazine - administration & dosage | Soft Tissue Neoplasms - mortality | Solitary Fibrous Tumors - drug therapy | Solitary Fibrous Tumors - mortality | Cerebellar Neoplasms - mortality | Ketones - administration & dosage | Survival Rate | Tetrahydroisoquinolines - administration & dosage | Pleural Neoplasms - mortality | Kidney Neoplasms - mortality | Mice, SCID | Blotting, Western | Meningeal Neoplasms - mortality | Xenograft Model Antitumor Assays | Disease-Free Survival | Animals | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Kidney Neoplasms - drug therapy | Furans - administration & dosage | Analysis | Melanoma | Stem cells | Anthracyclines | Cancer
Journal Article
Lancet Oncology, ISSN 1470-2045, 2014, Volume 15, Issue 4, pp. 415 - 423
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 6, pp. 976 - 983
Purpose To evaluate trastuzumab (H) and docetaxel (T) with or without capecitabine (X) as first-line combination therapy for human epidermal growth factor... 
SURVIVAL | COMBINATIONS | MULTICENTER | ONCOGENE | AMPLIFICATION | EFFICACY | ONCOLOGY | SAFETY | PRETREATED PATIENTS | ANTIBODY | PACLITAXEL | Prognosis | Receptor, ErbB-2 - genetics | Capecitabine | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Bone Neoplasms - secondary | Soft Tissue Neoplasms - drug therapy | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Feasibility Studies | Young Adult | Antibodies, Monoclonal, Humanized | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Female | Bone Neoplasms - drug therapy | Liver Neoplasms - secondary | Fluorouracil - analogs & derivatives | Soft Tissue Neoplasms - secondary | Deoxycytidine - administration & dosage | Liver Neoplasms - drug therapy | Soft Tissue Neoplasms - metabolism | In Situ Hybridization, Fluorescence | Survival Rate | Treatment Outcome | Breast Neoplasms - drug therapy | Taxoids - administration & dosage | International Agencies | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Liver Neoplasms - metabolism | Aged | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Trastuzumab | Liver Neoplasms | Breast Neoplasms | Life Sciences | Immunology | Taxoids | Fluorouracil | Antineoplastic Combined Chemotherapy Protocols | Antibodies, Monoclonal | Bone Neoplasms | Receptor, erbB-2 | Deoxycytidine | Soft Tissue Neoplasms
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 76, pp. 60 - 67
Journal Article